michael tung
aclaris therapeutics
vice president, investor relations
Dr. Michael Tung, M.D., is the vice president of investor relations at Aclaris Therapeutics. Dr. Tung focuses on oversight and management of the company’s relationship with the investment community and corporate communications. He has more than 15 years of healthcare buy-side experience and was most recently a senior portfolio manager at Turner Investments, where he conducted fundamental analysis of healthcare companies in all capitalization ranges to generate investment ideas for the firm's growth, global/international, and long/short separately managed accounts and mutual funds. Prior to this, Dr. Tung served as a senior analyst at Expo Capital Management and served as a vice president and portfolio manager at Delaware Investments. He began his professional career in the medical field, first as a physician at the Lemuel Shattuck Hospital of the Tufts University School of Medicine and then as an anesthesiologist at Beth Israel Deaconess Medical Center at the Harvard Medical School. Dr. Tung is a licensed physician in Massachusetts and New York. He earned a dual medical doctorate and master's in business administration from Tufts University School of Medicine in 2001 and a bachelor of science degree in biology and a bachelor of arts degree in economics from George Washington University in 1997.